Patient and Prescriber Survey: Effectiveness measures to investigate awareness, knowledge and adherence to the Risk Minimisation Measures (RMMs) of the Pregnancy Prevention Program (PPP) for Oral Retinoids (Acitretin, Alitretinoin, and Isotretinoin)

16/11/2020
28/02/2024
EU PAS number:
EUPAS38096
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

20200727_Oral Retinoids_PASS_Survey_Protocol_v5.0_Redacted_NO ANNEX

English (2.71 MB - PDF) View document
Study results
Study results

38096_20220215 Oral Retinoids_PASS_Survey_Final Report_v1.0_Abstract

English (228.94 KB - PDF) View document
Study report
Other information